Holds a technical degree in Chemistry from the Federal Institute of Alagoas (IFAL, 2018) and a Bachelor's degree in Biological Sciences from the Federal University of Alagoas (UFAL, 2023). Ranked second in the selection process for the PhD program in Genetics and Molecular Biology at the University of Campinas (PPG-GBM/UNICAMP CAPES score 7), and was awarded a scholarship from the Academic Excellence Program (PROEX/CAPES). Currently, he is a FAPESP-funded Direct PhD student in the Immunology division of the PPG-GBM and participates in the Teaching Internship Program (PED B) for the course Genetics for Nursing I. His doctoral research is conducted at the Boldrini Childrens Center (CPB), specifically in the Therapeutic Antibodies Laboratory, where he investigates the therapeutic potential of novel murine and chimeric monoclonal antibodies for the treatment of pediatric Acute Lymphoblastic Leukemia (ALL). He has experience in monoclonal antibody production, cell culture, protein purification and quantification, flow cytometry, molecular biology techniques, and in vivo assays using mouse models. Contact: jfeitoza658@gmail.com (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The lymphoid leukemias are hematologic neoplasms in the B and T lineages and are the major cause of infant death caused by cancer. About 10% of the ALL-T and 2% of the ALL-B present a leukemogenic mechanism caused by activating mutations in the gene encoding the hIL7R± protein (± chain of the human 7 interleukin receptor). The IL7R± is a protein expressed on the lymphocyte surfaces, it is…
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships in Brazil |
| 2 / 2 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID